Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9UKT7

Entry ID Method Resolution Chain Position Source
4I6J X-ray 270 A B 1-428 PDB
AF-Q9UKT7-F1 Predicted AlphaFoldDB

201 variants for Q9UKT7

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000767371
CA388320470
rs374431043
149 R>* Intellectual disability, short stature, facial anomalies, and joint dislocations [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
VAR_082209 149 R>del IDDSFAS [UniProt] Yes UniProt
rs764008859
RCV000767372
295 L>missing Intellectual disability, short stature, facial anomalies, and joint dislocations [ClinVar] Yes ClinVar
dbSNP
CA388317235
RCV000767373
VAR_082210
rs1566225872
358 C>R Intellectual disability, short stature, facial anomalies, and joint dislocations IDDSFAS [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs758124709
CA7007515
3 R>Q No ClinGen
ExAC
gnomAD
rs752598486
CA7007514
5 G>R No ClinGen
ExAC
gnomAD
rs199677324
CA252185004
7 D>E No ClinGen
1000Genomes
TOPMed
CA252185007
rs764791962
7 D>H No ClinGen
gnomAD
CA388322199
rs764791962
7 D>N No ClinGen
gnomAD
CA7007513
rs779089895
8 S>N No ClinGen
ExAC
gnomAD
CA388322174
rs1384283923
9 D>E No ClinGen
gnomAD
rs755236079
CA7007512
10 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA7007511
rs754093926
10 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs754093926
CA252185000
10 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA388322156
rs1380868444
12 S>L No ClinGen
gnomAD
CA388322154
rs1179294511
13 S>P No ClinGen
gnomAD
rs756859518
CA252184996
16 G>R No ClinGen
Ensembl
CA388322111
rs766385956
18 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA7007510
rs766385956
18 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs760810775
CA7007509
21 S>F No ClinGen
ExAC
gnomAD
rs1241508808
CA388322070
21 S>P No ClinGen
TOPMed
gnomAD
CA388322065
rs760810775
21 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA7007507
rs193234231
22 K>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs1203765127
CA388322053
22 K>R No ClinGen
gnomAD
CA388322045
rs1353551240
23 K>Q No ClinGen
gnomAD
CA7007504
rs1003951744
26 T>I No ClinGen
TOPMed
CA388321986
rs1380001729
27 T>A No ClinGen
TOPMed
gnomAD
rs1313907109
CA388321930
31 S>P No ClinGen
gnomAD
CA252184937
COSM1639378
rs904456346
32 Q>* stomach [Cosmic] No ClinGen
cosmic curated
Ensembl
rs769172956
CA7007502
33 T>A No ClinGen
ExAC
gnomAD
rs1486744567
CA388321901
33 T>N No ClinGen
TOPMed
rs373585221
CA252184930
36 W>L No ClinGen
ESP
CA388321647
rs1360553215
37 G>S No ClinGen
gnomAD
rs1389511778
CA388321606
42 D>V No ClinGen
gnomAD
CA252184919
rs199988301
43 I>V No ClinGen
Ensembl
rs201719570
CA252184915
49 K>Q No ClinGen
Ensembl
rs770501959
CA7007499
49 K>T No ClinGen
ExAC
gnomAD
rs746596303
CA7007498
54 L>H No ClinGen
ExAC
TOPMed
gnomAD
CA388321528
rs1361056308
54 L>V No ClinGen
gnomAD
CA7007497
rs777558812
55 D>E No ClinGen
ExAC
gnomAD
COSM1367716
CA388321516
rs1383545118
56 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs772100049
CA7007496
57 A>S No ClinGen
ExAC
gnomAD
rs747868204
CA7007495
57 A>V No ClinGen
ExAC
gnomAD
rs754793412
CA7007493
58 H>R No ClinGen
ExAC
gnomAD
CA7007494
rs778642310
58 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1488190074
CA388321466
64 R>C No ClinGen
gnomAD
rs753990250
CA7007492
64 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs780319441
CA388321460
65 N>I No ClinGen
ExAC
TOPMed
gnomAD
rs371851666
CA388321457
65 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780319441
CA7007491
65 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs780319441
CA388321459
65 N>T No ClinGen
ExAC
TOPMed
gnomAD
rs367807769
CA7007489
69 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA388321409
rs1285430756
72 M>K No ClinGen
TOPMed
rs922294840
CA252184851
72 M>L No ClinGen
TOPMed
gnomAD
rs922294840
CA252184853
72 M>V No ClinGen
TOPMed
gnomAD
rs767878877
CA388321350
80 E>K No ClinGen
ExAC
gnomAD
rs767878877
CA7007488
80 E>Q No ClinGen
ExAC
gnomAD
CA7007487
rs762339853
85 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs976513633
CA388321307
86 P>S No ClinGen
gnomAD
CA252184842
rs976513633
86 P>T No ClinGen
gnomAD
CA388321302
rs1299961095
87 A>T No ClinGen
gnomAD
CA252184839
rs200924298
89 S>T No ClinGen
TOPMed
rs764497283
CA7007485
91 L>F No ClinGen
ExAC
gnomAD
rs371133632
CA7007484
98 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7007483
rs776419080
99 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA7007482
rs770675461
100 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA388321126
rs1196305170
103 I>T No ClinGen
gnomAD
rs1264431793
CA388321131
103 I>V No ClinGen
gnomAD
rs1489988724
CA388321098
105 R>K No ClinGen
gnomAD
CA252184831
rs796829861
108 N>T No ClinGen
TOPMed
TCGA novel 115 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7007453
rs772764851
126 A>T No ClinGen
ExAC
gnomAD
rs761377191
CA7007451
130 I>V No ClinGen
ExAC
gnomAD
CA388320672
rs1177245925
132 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs749047548
CA7007448
138 S>P No ClinGen
ExAC
gnomAD
TCGA novel 142 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7007447
rs775314543
142 L>V No ClinGen
ExAC
gnomAD
TCGA novel 143 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs370379122
CA7007446
145 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138133067
CA7007445
146 S>* No ClinGen
ESP
ExAC
CA388320487
rs1315214026
147 T>S No ClinGen
TOPMed
rs1239596856
CA388320474
148 A>V No ClinGen
gnomAD
rs374431043
CA252183672
149 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1482803798
CA388320467
149 R>Q No ClinGen
gnomAD
CA7007442
rs747145560
152 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1315013976
CA388320412
153 M>T No ClinGen
gnomAD
rs1461073390
CA388320402
154 D>Y No ClinGen
TOPMed
CA388320202
rs1420774136
158 S>C No ClinGen
TOPMed
gnomAD
CA388320198
rs1420774136
158 S>F No ClinGen
TOPMed
gnomAD
rs779295651
CA7007414
159 H>P No ClinGen
ExAC
gnomAD
TCGA novel 159 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA388320155
rs1457005101
161 I>M No ClinGen
TOPMed
gnomAD
CA388320118
rs1367466203
165 T>I No ClinGen
TOPMed
CA7007411
rs201531118
169 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 172 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751234212
CA7007409
175 S>Y No ClinGen
ExAC
gnomAD
COSM253720
rs560551710
CA7007408
176 S>L urinary_tract [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs752676139
CA7007406
177 L>R No ClinGen
ExAC
gnomAD
rs1277900686
CA388319902
182 T>N No ClinGen
gnomAD
rs765146279
CA7007405
183 P>Q No ClinGen
ExAC
gnomAD
CA388319829
rs1283637983
187 P>L No ClinGen
gnomAD
CA7007402
rs770884350
190 K>E No ClinGen
ExAC
gnomAD
rs760932907
CA7007401
190 K>R No ClinGen
ExAC
rs1593928803
CA388319743
195 N>K No ClinGen
Ensembl
rs1422497382
CA388319723
197 S>G No ClinGen
TOPMed
gnomAD
rs1227107106
CA388319703
198 D>G No ClinGen
TOPMed
rs879147435
CA252182477
205 M>I No ClinGen
Ensembl
rs1375842051
CA388319555
213 P>S No ClinGen
gnomAD
CA7007397
rs779448827
214 A>T No ClinGen
ExAC
gnomAD
rs1566226219
CA388318882
216 I>M No ClinGen
Ensembl
rs1309529067
CA388318870
218 C>F No ClinGen
TOPMed
gnomAD
rs1309529067
CA388318872
218 C>Y No ClinGen
TOPMed
gnomAD
TCGA novel 220 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753618541
CA7007372
221 D>G No ClinGen
ExAC
gnomAD
CA388318855
rs1357085859
221 D>N No ClinGen
gnomAD
rs746288188
CA7007370
225 G>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 228 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA388318790
rs199748270
230 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs199748270
CA7007369
230 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1179351155
CA388318759
234 H>Q No ClinGen
TOPMed
gnomAD
CA7007368
rs758028722
234 H>Y No ClinGen
ExAC
gnomAD
rs565151928
CA252179641
237 S>T No ClinGen
Ensembl
rs775483274
CA252179637
239 E>G No ClinGen
Ensembl
TCGA novel 249 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA388318645
rs1462227471
251 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1566226148
CA388318622
254 H>L No ClinGen
Ensembl
CA388318614
rs1215174703
255 L>F No ClinGen
TOPMed
gnomAD
CA252179629
rs888492011
255 L>V No ClinGen
TOPMed
COSM3764483
CA7007364
rs753765117
256 R>C central_nervous_system [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA7007363
rs766494461
COSM275140
256 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs766494461
CA388318610
256 R>L No ClinGen
ExAC
gnomAD
rs1290004770
CA388318589
259 V>G No ClinGen
TOPMed
rs1224992538
CA388318574
262 E>Q No ClinGen
gnomAD
CA7007362
rs374182615
264 P>L No ClinGen
ESP
ExAC
gnomAD
rs1039802350
CA252179620
267 T>A No ClinGen
Ensembl
rs1283278542
CA388318535
267 T>I No ClinGen
gnomAD
rs943735886
CA252179617
268 H>R No ClinGen
Ensembl
CA388318532
rs1355430950
268 H>Y No ClinGen
TOPMed
CA388318505
rs1048504343
272 I>L No ClinGen
TOPMed
gnomAD
CA252179611
rs1048504343
272 I>V No ClinGen
TOPMed
gnomAD
CA7007360
rs767449785
279 A>V No ClinGen
ExAC
gnomAD
CA388318428
rs1243293815
282 R>K No ClinGen
gnomAD
rs202030737
CA252179604
285 P>S No ClinGen
1000Genomes
rs1402564584
CA388318404
286 K>Q No ClinGen
gnomAD
rs1411865046
CA388318401
286 K>T No ClinGen
gnomAD
rs764011537
CA7007357
289 L>S No ClinGen
ExAC
gnomAD
TCGA novel 294 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7007356
rs763159668
295 L>I No ClinGen
ExAC
gnomAD
rs1216357687
CA388318334
295 L>S No ClinGen
TOPMed
rs764008859 295 L>Y Variant assessed as Somatic; 0.0001495 impact. [NCI-TCGA] No NCI-TCGA
CA7007352
rs746200234
296 Y>C No ClinGen
ExAC
gnomAD
rs373258013
CA388318330
296 Y>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7007353
rs373258013
296 Y>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 300 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 301 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760763712
CA252179577
302 P>S No ClinGen
gnomAD
rs369788246
CA7007348
305 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs754446542
CA7007347
305 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA7007346
rs141339299
306 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA252179565
rs573517886
308 I>T No ClinGen
TOPMed
gnomAD
CA7007345
rs780103627
308 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1300011178
CA388318231
310 A>V No ClinGen
gnomAD
rs1555275091
CA388318218
312 H>R No ClinGen
Ensembl
rs1375531139
CA388318174
319 V>I No ClinGen
TOPMed
rs373072488
CA252179552
322 D>N No ClinGen
ESP
rs1593921137
CA388318149
322 D>V No ClinGen
Ensembl
CA7007342
rs767156725
324 L>R No ClinGen
ExAC
CA388318126
rs1440959774
326 R>C No ClinGen
TOPMed
TCGA novel 327 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 331 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs869051475
CA252179543
343 G>V No ClinGen
Ensembl
CA7007338
rs762998083
345 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1221689576
CA388317391
349 E>D No ClinGen
gnomAD
rs745444479
CA7007335
353 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA388317322
rs745444479
353 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs759989436
CA7007334
357 R>C No ClinGen
ExAC
gnomAD
rs1338037603
CA388317207
360 N>H No ClinGen
gnomAD
rs771136982
CA7007332
364 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA388317115
rs1566225840
367 G>A No ClinGen
Ensembl
rs375666314
CA7007328
369 C>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7007327
rs779659265
370 E>K No ClinGen
ExAC
gnomAD
CA388317004
rs1178134325
382 M>I No ClinGen
TOPMed
rs1394857989
CA388316981
386 R>C No ClinGen
TOPMed
rs756988737
CA7007323
COSM948483
386 R>H Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TCGA novel 388 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1431894670
CA388316945
392 I>V No ClinGen
TOPMed
gnomAD
CA388316938
rs1191233744
393 M>V No ClinGen
gnomAD
TCGA novel 394 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1395119742
CA388316916
395 E>D No ClinGen
TOPMed
CA7007320
rs777828187
396 V>E No ClinGen
ExAC
gnomAD
CA388316904
rs1457940322
398 I>L No ClinGen
gnomAD
CA7007318
rs752940172
400 D>H No ClinGen
ExAC
gnomAD
rs1235087092
CA388316851
405 L>V No ClinGen
gnomAD
CA388316819
rs1446244000
409 H>P No ClinGen
gnomAD
rs1326336613
CA388316815
409 H>Q No ClinGen
TOPMed
rs1307343175
CA388316820
409 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA388316814
rs1355916066
410 W>R No ClinGen
TOPMed
rs1566225724
CA388316778
414 K>N No ClinGen
Ensembl
rs760929977
CA7007313
420 W>* No ClinGen
ExAC
gnomAD
CA7007311
rs772342610
COSM1206781
423 D>N large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs767543712
CA252179496
425 M>L No ClinGen
Ensembl

1 associated diseases with Q9UKT7

[MIM: 606220]: Intellectual developmental disorder with short stature, facial anomalies, and speech defects (IDDSFAS)

An autosomal recessive disorder characterized by global developmental delay, mildly to severely impaired intellectual development, delayed or slurred speech, and short stature. Dysmorphic features included a large bulbous nose and variable microretrognathia. Some patients show joint hyperlaxity and dislocations. {ECO:0000269|PubMed:30481285}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal recessive disorder characterized by global developmental delay, mildly to severely impaired intellectual development, delayed or slurred speech, and short stature. Dysmorphic features included a large bulbous nose and variable microretrognathia. Some patients show joint hyperlaxity and dislocations. {ECO:0000269|PubMed:30481285}. Note=The disease is caused by variants affecting the gene represented in this entry.

1 regional properties for Q9UKT7

Type Name Position InterPro Accession
domain F-box domain 39 - 79 IPR001810

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Predominantly nuclear
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
SCF ubiquitin ligase complex A ubiquitin ligase complex in which a cullin from the Cul1 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a Skp1 adaptor and an F-box protein. SCF complexes are involved in targeting proteins for degradation by the proteasome. The best characterized complexes are those from yeast and mammals (with core subunits named Cdc53/Cul1, Rbx1/Hrt1/Roc1).
ubiquitin ligase complex A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.

1 GO annotations of molecular function

Name Definition
ubiquitin-protein transferase activity Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.

8 GO annotations of biological process

Name Definition
entrainment of circadian clock by photoperiod The synchronization of a circadian rhythm to photoperiod, the intermittent cycle of light (day) and dark (night).
G2/M transition of mitotic cell cycle The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.
protein destabilization Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation.
protein ubiquitination The process in which one or more ubiquitin groups are added to a protein.
regulation of cell cycle Any process that modulates the rate or extent of progression through the cell cycle.
regulation of circadian rhythm Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours.
rhythmic process Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism.
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8N4B4 FBXO39 F-box only protein 39 Homo sapiens (Human) PR
Q8N461 FBXL16 F-box/LRR-repeat protein 16 Homo sapiens (Human) PR
Q8BH70 Fbxl4 F-box/LRR-repeat protein 4 Mus musculus (Mouse) PR
Q8C4V4 Fbxl3 F-box/LRR-repeat protein 3 Mus musculus (Mouse) PR
Q9LTX2 At5g49980 Transport inhibitor response 1-like protein Arabidopsis thaliana (Mouse-ear cress) PR
Q9ZR12 GRH1 GRR1-like protein 1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MKRGGRDSDR NSSEEGTAEK SKKLRTTNEH SQTCDWGNLL QDIILQVFKY LPLLDRAHAS
70 80 90 100 110 120
QVCRNWNQVF HMPDLWRCFE FELNQPATSY LKATHPELIK QIIKRHSNHL QYVSFKVDSS
130 140 150 160 170 180
KESAEAACDI LSQLVNCSLK TLGLISTARP SFMDLPKSHF ISALTVVFVN SKSLSSLKID
190 200 210 220 230 240
DTPVDDPSLK VLVANNSDTL KLLKMSSCPH VSPAGILCVA DQCHGLRELA LNYHLLSDEL
250 260 270 280 290 300
LLALSSEKHV RLEHLRIDVV SENPGQTHFH TIQKSSWDAF IRHSPKVNLV MYFFLYEEEF
310 320 330 340 350 360
DPFFRYEIPA THLYFGRSVS KDVLGRVGMT CPRLVELVVC ANGLRPLDEE LIRIAERCKN
370 380 390 400 410 420
LSAIGLGECE VSCSAFVEFV KMCGGRLSQL SIMEEVLIPD QKYSLEQIHW EVSKHLGRVW
FPDMMPTW